Ketorolac Tromethamine
NDC Package 0548-9021-00
Package Information
Ketorolac Tromethamine is ketorolac is used for the short-term treatment of moderate to severe pain. Marketed by Amphastar Pharmaceuticals, Inc., this product is identified by NDC 0548-9021 and is authorized under FDA application ANDA076209.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0548 - Amphastar Pharmaceuticals, Inc.
- 0548-9021 - Ketorolac Tromethamine
- 0548-9021-00 - 10 VIAL in 1 CARTON / 1 mL in 1 VIAL
- 0548-9021 - Ketorolac Tromethamine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0548-9021-00 identifies a specific commercial package of 10 vial in 1 carton / 1 ml in 1 vial of Ketorolac Tromethamine, labeled by Amphastar Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Amphastar Pharmaceuticals, Inc. on March 11, 2016. The current certification is valid through June 30, 2019.
What are the primary indications for this medication?
Ketorolac is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever. Ketorolac should not be used for mild or long-term painful conditions (such as arthritis).
How is this Amphastar Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00548902100. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.